Nexium (Esomeprazole Magnesium)

Esomeprazole magnesium, the active ingredient in Nexium, is a proton pump inhibitor presented as an oral tablet for oral use. By inhibiting the gastric H+/K+ ATPase, it reduces gastric acid secretion and is indicated for conditions such as gastro‑oesophageal reflux disease, erosive esophagitis, Helicobacter pylori eradication regimens, and Zollinger‑Ellison syndrome.

GNH USA supplies Nexium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nexium, a proton pump inhibitor, acts on the gastric acid secretion pathway to manage acid‑related disorders. - Gastro‑oesophageal reflux disease (GERD): relief of heartburn and promotion of esophageal healing. - Erosive esophagitis: reduction of mucosal damage and acceleration of ulcer resolution. - Helicobacter pylori eradication regimen: enhances the effectiveness of antibiotic combinations by suppressing gastric acid. - Zollinger‑Ellison syndrome: control of excessive gastric acid production associated with gastrin‑secreting tumors.

Common Side Effects: - Headache: mild to moderate pain often reported during early therapy. - Diarrhea: loose stools that may resolve with continued use. - Nausea: transient feeling of queasiness. - Abdominal pain: discomfort in the stomach region. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or anaphylaxis requiring immediate medical attention. - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Low serum magnesium: may cause muscle cramps, weakness, or cardiac arrhythmias. - Bone fractures: increased risk with long‑term use due to altered calcium absorption. - Stevens‑Johnson syndrome: rare skin blistering disorder. - Hepatic injury: elevated liver enzymes or jaundice.

Before initiating therapy, consider the following precautions: - Assess renal function: dose adjustment may be required in severe renal impairment. - Monitor for infection: prolonged use can increase risk of gastrointestinal infections. - Review concomitant medications: drugs that need gastric acidity for absorption may have reduced efficacy. - Evaluate bone health: long‑term therapy may affect calcium absorption and increase fracture risk. - Store at room temperature: keep in the original container, protect from moisture and light.

Nexium may interact with several medicines; awareness of the interaction level helps guide management. Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir: decreased absorption of atazanavir, compromising HIV therapy. - High‑dose methotrexate: increased toxicity due to reduced renal clearance. - Warfarin: potential increase in INR, enhancing bleeding risk. Moderate Interactions (Monitor Closely): - Digoxin: elevated serum levels may require dose adjustment. - Diazepam: increased sedation due to higher plasma concentrations. - Phenytoin: reduced phenytoin levels may diminish seizure control.